Search Results - "glucose"

Managing hyperglycaemia in people with DM and CKD part 2, cardiovascular disease (CVD) involvement /

Table of Contents: “…Contents: The need to individualise glycaemic control in DKD -- The role of new agents in reducing development and progression of DKD -- The need for co-ordinated DM care in haemodialysis -- Logical and inappropriate combination blood glucose lowering therapies in DKD -- Safe management of DKD during acute illness.…”
Get full text

Managing hyperglycaemia in people with DM and CKD part 2, cardiovascular disease (CVD) involvement /

Table of Contents: “…Contents: The need to individualise glycaemic control in DKD -- The role of new agents in reducing development and progression of DKD -- The need for co-ordinated DM care in haemodialysis -- Logical and inappropriate combination blood glucose lowering therapies in DKD -- Safe management of DKD during acute illness.…”
Get full text

Cardiovascular prevention in type 2 diabetes

Table of Contents: “…Contents: Diabetes mellitus as an equivalent of cardiovascular disease and secular trends of cardiovascular outcomes -- Multi-factorial therapy as the golden treatment paradigm for cardiovascular prevention -- Statins in primary and secondary intervention -- Blood pressure lowering therapy under inclusion inhibition of the rennin-angiotensin-aldosterone system -- Outcome evidence of blood glucose lowering therapy.…”
Get full text
Series

Cardiovascular prevention in type 2 diabetes

Table of Contents: “…Contents: Diabetes mellitus as an equivalent of cardiovascular disease and secular trends of cardiovascular outcomes -- Multi-factorial therapy as the golden treatment paradigm for cardiovascular prevention -- Statins in primary and secondary intervention -- Blood pressure lowering therapy under inclusion inhibition of the rennin-angiotensin-aldosterone system -- Outcome evidence of blood glucose lowering therapy.…”
Get full text
Series

Cardiovascular prevention in type 2 diabetes

Table of Contents: “…Contents: Diabetes mellitus as an equivalent of cardiovascular disease and secular trends of cardiovascular outcomes -- Multi-factorial therapy as the golden treatment paradigm for cardiovascular prevention -- Statins in primary and secondary intervention -- Blood pressure lowering therapy under inclusion inhibition of the rennin-angiotensin-aldosterone system -- Outcome evidence of blood glucose lowering therapy.…”
Get full text
Series

The genetic basis of kidney cancer

Table of Contents: “…-- Folliculin-FNIP1/2-AMPK interactions -- mTORC1/mTORC2 activation: FLCN-deficient Kidney Cancer -- BHD deletion specifically in the kidney -- BHDf/d/KSPCre mouse kidney study -- Hereditary Leiomyomatosis Renal Cell Carcinoma (HLRCC) -- HLRCC: cutaneous manifestations, Uterine Leiomyomas -- HLRCC: Papillary Kidney Cancer Type 2 -- Orangophilic nucleoli + Perinucleolar halos -- Fumarate Hydratase gene: HLRCC -- UOK-262 study -- Loss of a Krebs Cycle Enzyme can lead to Kidney Cancer -- Impaired citric acid cycle and "Warburg effect" -- HLRCC-Renal Cancer: glucose-dependent -- PET scan -- HLRCC novel treatment approaches -- Kidney cancer: a metabolic disease.…”
Get full text
Series (Molecular genetics of human disease)
Series (Kidney in health and disease)

The genetic basis of kidney cancer

Table of Contents: “…-- Folliculin-FNIP1/2-AMPK interactions -- mTORC1/mTORC2 activation: FLCN-deficient Kidney Cancer -- BHD deletion specifically in the kidney -- BHDf/d/KSPCre mouse kidney study -- Hereditary Leiomyomatosis Renal Cell Carcinoma (HLRCC) -- HLRCC: cutaneous manifestations, Uterine Leiomyomas -- HLRCC: Papillary Kidney Cancer Type 2 -- Orangophilic nucleoli + Perinucleolar halos -- Fumarate Hydratase gene: HLRCC -- UOK-262 study -- Loss of a Krebs Cycle Enzyme can lead to Kidney Cancer -- Impaired citric acid cycle and "Warburg effect" -- HLRCC-Renal Cancer: glucose-dependent -- PET scan -- HLRCC novel treatment approaches -- Kidney cancer: a metabolic disease.…”
Get full text
Series (Molecular genetics of human disease)
Series (Kidney in health and disease)

The genetic basis of kidney cancer

Table of Contents: “…-- Folliculin-FNIP1/2-AMPK interactions -- mTORC1/mTORC2 activation: FLCN-deficient Kidney Cancer -- BHD deletion specifically in the kidney -- BHDf/d/KSPCre mouse kidney study -- Hereditary Leiomyomatosis Renal Cell Carcinoma (HLRCC) -- HLRCC: cutaneous manifestations, Uterine Leiomyomas -- HLRCC: Papillary Kidney Cancer Type 2 -- Orangophilic nucleoli + Perinucleolar halos -- Fumarate Hydratase gene: HLRCC -- UOK-262 study -- Loss of a Krebs Cycle Enzyme can lead to Kidney Cancer -- Impaired citric acid cycle and "Warburg effect" -- HLRCC-Renal Cancer: glucose-dependent -- PET scan -- HLRCC novel treatment approaches -- Kidney cancer: a metabolic disease.…”
Get full text
Series (Molecular genetics of human disease)
Series (Kidney in health and disease)

Merritt's neurology.

Table of Contents: “…Head injury -- Spine injury -- Cranial and peripheral nerve lesions -- Complex regional pain syndrome -- Radiation injury -- Electrical and lightning injury -- Decompression sickness -- Intervertebral dics and radiculopathy -- Cervical spondylotic myelopathy -- Thoracic outlet syndrome -- Hereditary and acquired spastic paraplegia -- Syringomyelia -- Neonatal neurology -- Floppy infant syndrome -- Disorders of motor and mental development -- Autism spectrum disorders -- Laurence-Moon-Biedl syndrome -- Cerebral and spinal malformations -- Chromosomal diseases -- Marcus Gunn -- Möbius syndrome -- Disorders of amino acid metabolism -- Disorders of purine and pyrimidine metabolism -- Lysosomal and other storage diseases -- Disorders of carbohydrate metabolism -- Glucose transporter type 1 deficiency syndrome -- Disorders of DNA maintenance, transcription, and translation -- Hyperammonemia -- Peroxisomal diseases: adrenoleukodystrophy, zellweger syndrome, and refsum disease -- Organic acidurias -- Disorders of metal metabolism -- Acute intermittent porphyria -- Neurologic syndromes with acanthocytes -- Cerebral degenerations of childhood -- Diffuse sclerosis and vanishing white matter disease -- Mitochondrial encephalomyopathies: diseases of mitochondrial DNA -- Leber hereditary optic neuropathy -- Mitochondrial diseases with mutations of nuclear DNA -- Neurofibromatosis -- Tuberous sclerosis complex -- Encephalotrigeminal angiomatosis -- Incontinentia pigmenti -- General considerations -- Alzheimer disease -- Frontotemporal dementia -- Lewy body dementias -- Huntington disease -- Choreas -- Myoclonus -- Gilles de la tourette syndrome -- Dystonia -- Essential tremor -- Parkinson disease -- Parkinson-plus syndromes -- Paroxysmal dyskinesias -- Tradive dyskinesia and other neuroleptic-induced syndromes -- Autosomal recessive ataxias -- Autosomal dominant ataxias -- Amyotrophic lateral sclerosis, progressive muscular atrophy, and primary lateral sclerosis -- Kennedy disease -- Spinal muscular atrophies of childhood -- Monomelic muscular atrophy -- General considerations -- The inherited peripheral neuropathies -- Acquired neuropathies -- Neuropathic pain -- Myasthenia gravis -- Lambert-Eaton syndrome -- Botulism and antibiotic-induced neuromuscular disorders -- Critical illness myopathy and neuropathy -- Identifying disorders of the motor unit --…”
An electronic book accessible through the World Wide Web; click to view